angiotensin ii has been researched along with tin mesoporphyrin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, NG; Goodman, A; Lombardo, G; Mazza, F; Vanella, A | 1 |
Croatt, AJ; Hernandez, MC; Juncos, LA; Katusic, ZS; Nath, KA | 1 |
2 other study(ies) available for angiotensin ii and tin mesoporphyrin
Article | Year |
---|---|
Heme oxygenase-1 gene expression attenuates angiotensin II-mediated DNA damage in endothelial cells.
Topics: Angiotensin II; Biliverdine; Cell Size; Cells, Cultured; Comet Assay; DNA Damage; Endothelium, Vascular; Enzyme Inhibitors; Genetic Vectors; Glutathione; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Hydrogen Peroxide; Membrane Proteins; Metalloporphyrins; Oxidants; Oxidative Stress; Retroviridae | 2003 |
Heme oxygenase activity as a determinant of the renal hemodynamic response to low-dose ANG II.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Hemodynamics; Infusion Pumps, Implantable; Infusions, Intravenous; Kidney; Male; Mesenteric Arteries; Metalloporphyrins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renal Circulation; RNA, Messenger; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2010 |